Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Mathilde Rauline has worked on the following 10 EPO patent applications which have been published in the last five years:

EP12305415

Use of an h3 receptor antagonist for the treatment of alzheimer's disease

IPC classification:
A61K 31/4725, A61P 25/00
Applicant:
Sanofi, S.A.
Agent:
Mathilde Rauline, Sanofi
Status:
APPLICATION REFUSED
EP11731176

SUBSTITUTED N-PHENYL SPIROLACTAM BIPYRROLIDINES, PREPARATION AND THERAPEUTIC USE THEREOF

IPC classification:
A61K 31/403, A61P 25/00, C07D 401/10, C07D 403/10
Applicant:
Sanofi, S.A.
Agent:
Mathilde Rauline, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11731171

SUBSTITUTED N-ALKYL AND N-ACYL TETRAHYDRO-ISOQUINOLINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF

IPC classification:
A61K 31/4709, A61P 25/00, C07D 401/14, C07D 403/04, C07D 407/14, C07D 495/04
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Mathilde Rauline, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11731172

Substituted N-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof

IPC classification:
A61K 31/407, A61K 31/438, A61K 31/4439, A61P 25/16, A61P 25/18, A61P 25/24, A61P 25/28, C07D 401/14, C07D 471/10, C07D 491/107
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Mathilde Rauline, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11306170

Bi-aryl derivatives, their preparation and their therapeutic application

IPC classification:
A61K 31/196, A61K 31/216, A61P 27/06, C07C 217/84
Applicant:
Fovea Pharmaceuticals SA
Agent:
Claude Jacobson, Cabinet Lavoix
Agent:
Mathilde Rauline, Fovea Pharmaceuticals SA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12305130

2-(3-aminophenoxy)-acetic acid derivatives as EP2 receptor agonists for use in treatment of glaucoma

IPC classification:
A61K 31/196, A61P 27/02, C07C 217/84
Applicant:
Fovea Pharmaceuticals SA
Agent:
Claude Jacobson, Cabinet Lavoix
Agent:
Mathilde Rauline, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11731175

SUBSTITUTED N-HETEROCYCLOALKYL BIPYRROLIDINYLPHENYL AMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF

IPC classification:
A61K 31/351, A61K 31/4439, A61P 25/00, C07D 401/12, C07D 405/12
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Mathilde Rauline, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11731173

Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof

IPC classification:
A61K 31/40, A61K 31/403, A61K 31/407, A61K 31/438, A61K 31/453, A61K 31/4535, A61K 31/454, C07D 207/06, C07D 401/12, C07D 403/10, C07D 405/12, C07D 409/12, C07D 413/12, C07D 471/10, C07D 491/107
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Mathilde Rauline, Sanofi
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11731174

SUBSTITUTED N-HETEROARYL TETRAHYDRO-ISOQUINOLINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF

IPC classification:
A61K 31/4709, A61P 25/00, C07D 401/14, C07D 403/14, C07D 413/14
Applicant:
Sanofi, S.A.
Agent:
Mathilde Rauline, Sanofi
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11725830

SUBSTITUTED N-HETEROARYL BIPYRROLIDINE CARBOXAMIDES, PREPARATION AND THERAPEUTIC USE THEREOF

IPC classification:
A61K 31/4427, A61P 37/08, C07D 401/04, C07D 403/14
Applicant:
Sanofi, S.A.
Agent:
Mathilde Rauline, Sanofi
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature